NeoVanc: Treatment of late onset bacterial sepsis caused by Vancomycin susceptible bacteria in neonates and infants aged under three months (RTD Budget) - Edinburgh Research Explorer

Edinburgh Research Explorer

NeoVanc: Treatment of late onset bacterial sepsis caused by Vancomycin susceptible bacteria in neonates and infants aged under three months (RTD Budget)

Project: Research

Ghazal, Peter (Principal Investigator)

Status	Finished
Effective start/end date	1/02/14 → 31/01/19

Total award	£125,504.00
Funding organisation	EU government bodies
Funder project reference	602041

Total award	£1,835.00
Funding organisation	EU government bodies
Funder project reference	602041

Period	1/02/14 → 31/01/19